Parallel Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.34M | Sell |
|
|||||
|
2025
Q1 | $2.64M | Sell |
|
|||||
|
2024
Q4 | $2.95M | Buy |
|
|||||
|
2024
Q3 | $3.34M | Buy |
|
|||||
|
2024
Q2 | $2.99M | Buy |
|
|||||
|
2024
Q1 | $2.3M | Buy |
|
|||||
|
2023
Q4 | $1.94M | Buy |
|
|||||
|
2023
Q3 | $1.21M | Buy |
|
|||||
|
2023
Q2 | $1.13M | Buy |
|
|||||
|
2023
Q1 | $960K | Buy |
|
|||||
|
2022
Q4 | $637K | Buy |
|
|||||
|
2022
Q3 | $632K | Buy |
|
|||||
|
2022
Q2 | $570K | Buy |
|
|||||
|
2022
Q1 | $501K | Buy |
|
|||||
|
2021
Q4 | $407K | Buy |
|
|||||
|
2021
Q3 | $263K | Buy |
|
|||||
|
2021
Q2 | $270K | Buy |
|
|||||
|
2021
Q1 | $272K | Buy |
|
|||||
|
2020
Q4 | $294K | Sell |
|
|||||
|
2020
Q3 | $375K | Sell |
|
|||||
|
2020
Q2 | $415K | Buy |
|
|||||
|
2020
Q1 | $303K | Buy |
|
|||||
|
2019
Q4 | $247K | Buy |
|
|||||
|
2019
Q3 | $183K | Buy |
|
|||||
|
2019
Q2 | $172K | Sell |
|
|||||
|
2019
Q1 | $184K | Sell |
|
|||||
|
2018
Q4 | $180K | Buy |
|
|||||
|
2018
Q3 | $199K | Buy |
|
|||||
|
2018
Q2 | $173K | Buy |
|
|||||
|
2018
Q1 | $137K | Buy |
|
|||||
|
2017
Q4 | $122K | Sell |
|
|||||
|
2017
Q3 | $123K | Buy |
|
|||||
|
2017
Q2 | $116K | Sell |
|
|||||
|
2017
Q1 | $92K | Buy |
|
|||||
|
2016
Q4 | $44K | Buy |
|